Analyzing Madrigal Pharmaceuticals' potential in the competitive NASH drug market and why it may be right for your portfolio.
Kroger Health, the arm of grocer Kroger that runs pharmacies and clinics across the U.S., said on Friday it had revamped its ...
Talking about weight and weight loss with Johann Hari, an Ozempic user and the author of "Magic Pill: The Extraordinary ...
Learn about the side effects of Ozempic, Wegovy, Mounjaro and Zepbound, so you can weigh the risks versus benefits.
For the past year and a half, Tandra Cooper Harris and her husband, Marcus, who both have diabetes, have struggled to fill ...
Share on Pinterest Metabolic and bariatric surgery is more effective for long-term weight loss than lifestyle changes and GLP-1 medications like Ozempic, Wegovy, and Zepbound. Nastasic/Getty ...
Taking a cutting-edge weight-loss drug could help extremely obese patients drop enough pounds to be eligible for bariatric surgery, a new study shows. Patients with extreme obesity -- a BMI of 70 ...
Blue Cross Blue Shield of Michigan intends to drop coverage of GLP-1 obesity drugs for certain plans due to concerns about their cost, safety and efficacy, according to Bloomberg. The health ...
Obesity-Diabetes Drugs MarketAs per Future Market Insights’ latest industry analysis, the global obesity-diabetes drugs market was valued at around USD 54,452.0 million in 2023 and is anticipated to ...
Boehringer Ingelheim today announced breakthrough results from a survodutide Phase II trial sub-analysis that demonstrate up to 64.5% of adults with fibrosis stages F2 and F3 (moderate to advanced ...